Fennec Pharmaceuticals

-$0.07 (-1.06%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.

About FENC

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients.

CEO
Rostislav C. Raykov
Employees
9
Headquarters
Durham, North Carolina
Founded
1996

FENC Key Statistics

Market Cap
185.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
73.43K
High Today
$6.68
Low Today
$6.51
Open Price
$6.60
Volume
20.94K
52 Week High
$10.67
52 Week Low
$4.80

FENC Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure